Commit to R&D of innovative products to address unmet medical needs and to improve patients’ quality of life.
Pharmaceutical Products
Various products stemming from both internal R&D efforts and collaborations with partnerships
Research & Development
CLINCAL TRIALS
COVID-19 TESTING
PHARMACOVIGILANCE
MEDICAL FRONTIERS
Lee’s Pharmaceutical Holdings Limited is an investment holding company specialized in Development, Manufacturing, Sales & Marketing of internationally approved and qualified pharmaceutical products, which mainly focuses on China market. The company addresses a wide range of therapeutic areas, including: Cardiovascular health, Women’s health, Pediatrics, Rare diseases, Infectious diseases, Oncology, Dermatology, Obstetrics & Gynecology.
ผลิตภัณฑ์ที่พัฒนาขึ้นเองและผลิตภัณฑ์ยาสามัญ (Proprietary and Generic Products)
This segment includes development, manufacturing, and sale of self-developed and generic pharmaceutical products.
Key offerings include:
Nadroparin Calcium Injection and Fondaparinux Sodium Injection in remedy of blood clots and deep vein thrombosis.
Yallaferon to treat cervical erosion and viral infections.
Slounase for hemostasis.
Eyprotor is an impressive treatment for corneal ulcers.
Treprostinil Injection is a well-known remedy for pulmonary arterial hypertension.
Sodium Phenylbutyrate Granules are very effective in treatment of urea cycle disorders.
This segment involves trading pharmaceutical products licensed from other companies. Key products include:
Carnitene For carnitine deficiency.
Sancuso For chemotherapy-induced nausea and vomiting.
Bredinin For immunosuppression in renal transplantation.
Centraxal Plus For acute otitis media with tympanostomy tubes.
Episil For oral mucositis pain.
Ferplex For iron deficiency anemia.
Gaslon N For gastric ulcers and gastritis.
Overview: (1) Founded: 1994, (2) Headquarters: Sha Tin, Hong Kong Lee’s Pharmaceutical leverages a diverse portfolio of proprietary and exclusive along with licensed-in products to address unmet /unfulfilled medical needs across its target markets.